PIK3CA and cancer: Although mutant PIK3CA has been reported to be sufficient to transform normal cells both in vitro[44], [45], [46] and in vivo[46], [47], PIK3CA mutation exhibits a relatively low frequency in ovarian cancer (4.8–12%) [28], [29], [30], [32] as compared to other cancer types.